Traditionally the Latin America in all sectors of the knowledge and scientific production has faced the reality of developed countries, especially Europe and United States of America. This relationship in the area of health has always been complex because its natural assets always served for researches and later production and patenting of pharmaceuticals. In addition the entire base of medicinal products has always been geared towards the production of synthetic drugs. The aim with this article is to demonstrate that although social indicators have yet to be improved, we have bases to think of the advance of the democratization process in Latin America, allowing the execution of projects that lead to a sovereignty of health.
